The Clavam 625 from Alkem Laboratories Ltd - Indian bestseller antibiotic holds its ground

The Clavam 625 tablet combines amoxicillin and clavulanic acid and has become one of Alkem’s most prescribed antibiotic brands in India. This bestseller keeps the focus on Alkem Laboratories Ltd shares (ISIN INE540L01014).

Reviewed: ad hoc news Classics & Longseller desk. Edited and checked on 2026-06-30, 00:33. Details in the imprint.

The Clavam 625 tablet from Alkem Laboratories Ltd sits in millions of Indian medicine cabinets, a small white pill that family doctors reach for when a chest infection will not budge. You feel its presence on the prescription pad, a familiar name that patients recognize and often ask for by brand.

How Clavam 625 is built

Clavam 625 is a fixed-dose combination of amoxicillin and clavulanic acid, designed to tackle bacterial infections that simple penicillins no longer handle well. The numbers matter here: 500 mg of amoxicillin with 125 mg of potassium clavulanate in each tablet, taken typically twice daily for a short course.

On paper, that looks straightforward, but in practice it is about reliability. Dr. Deepak Bansal, a Delhi-based general practitioner, describes Clavam 625 as a "workhorse" for sinusitis and lower respiratory infections, something he reaches for when a patient has already tried a basic antibiotic and is still coughing hard.

Where patients feel the difference

For patients, Clavam 625 usually means a thicker blister pack, a slightly bitter tablet that softens quickly on the tongue if not swallowed fast. The dosage feels structured in daily life: one tablet with breakfast, one with dinner, often paired with a reminder note on the fridge to avoid missed doses.

Many users report that the first noticeable effect is not dramatic relief but a quiet easing of fever and body ache after a couple of days, then a less raw throat or calmer chest. That subtle, consistent improvement is why doctors such as Bansal stick with the brand rather than constantly rotating through newer names.

The doctor’s balancing act

The brand also carries a responsibility: amoxicillin-clavulanate combinations are powerful, but overuse can drive resistance and gut side effects. Doctors like Bansal often weigh Clavam 625 against culture reports, severity of illness and the patient’s antibiotic history before writing those three syllables on the pad.

In the clinic, this looks like a structured conversation. The physician explains why a stronger antibiotic is needed this time, warns about possible loose stools, and asks the patient to complete the full course even if they feel better after three days. That human guidance is part of why the brand remains trusted instead of feared.

Packaging, price and daily reality

Clavam 625 typically comes in blister strips of six or ten tablets, tucked into a modest cardboard box that fits easily in a crowded home medicine drawer. The pack is thin, the foil bright, and the pill itself smooth enough to swallow even for those who usually struggle with larger capsules.

For many Indian households, the price sits in a middle band: not the cheapest antibiotic option on the shelf, but not a premium outlier either. That balance makes it viable for repeat prescriptions in urban clinics, while still reachable for patients who pay out of pocket without insurance.

Role in Alkem’s portfolio and shares

Clavam 625 is part of Alkem’s broad anti-infective portfolio that has long anchored its presence in the Indian prescription market, alongside newer therapies in neurology, oncology and diabetes. The familiarity of the brand reinforces the company’s relationships with doctors across tier-1 and tier-2 cities.

Overall, this quiet mainstay helps stabilize cash flows and supports the Alkem Laboratories Ltd share price on its domestic listing in India, even as investors increasingly watch the company’s expansion into higher-margin chronic therapies.

Key facts on Clavam 625

• Product: Clavam 625 tablet
• Manufacturer: Alkem Laboratories Ltd
• Category: Classic longseller prescription antibiotic
• Launch: Established brand, widely prescribed in India since the 2000s
• RRP / Price: Mid-range pricing per strip in Indian rupees, varying by pharmacy and region
• Availability: Widely available in Indian retail pharmacies and hospital supply channels
• Target group: Adult and adolescent patients with bacterial infections where amoxicillin-clavulanate is indicated
• Highlight / USP: Trusted fixed-dose combination of amoxicillin and clavulanic acid in a 500 mg/125 mg tablet, widely recognized by doctors and patients

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.